Neurodiagnostics Market Growth & Trends
The global neurodiagnostics market size is expected to reach USD 22.99 billion by 2030,registering a CAGR of 3.8% from 2024 to 2030. Key factors driving the market growth include increasing prevalence of neurological diseases due to demographic changes and growing awareness of their management. In addition, consistent technological modifications coupled with increased preference for novel diagnostic technologies will further fuel the market. The economic burden of neurological diseases is extremely high on society and governments with around 1 billion people suffering globally.
Among all the neuroimaging techniques, computed tomography has the largest market share followed by Magnetic Resonance Imaging (MRI). Computed Tomography (CT) uses ionized radiations for the purpose of creating images, whereas MRI uses radio waves in a magnetic field. Neuroimaging techniques are used to detect brain injuries, developmental malformations in the brain area, vascular irregularities that may lead to stroke, epilepsy, etc.
Biomarkers are an important part of in vitro diagnostics for neurological disorders as their development is targeted at the early disease diagnosis with information about the nervous system. Although biomarkers are not commercially available in the market, their use is confined to clinical research settings. For instance, ELISA tests for Tau protein are available in clinical studies of Alzheimer’s disease. In addition, neuroinformatics is a field that studies neuroscience and information technology. This integration allows the storage of neurological data in the form of databases. The neuroinformatics market is expected to grow at the second-highest growth rate during the forecast period.
Neurodiagnostics Market Report Highlights
- Increased life expectancy has resulted in an increased geriatric population across the globe. The prevalence of aging-related neurological diseases such as Alzheimer’s disease and Parkinson’s disease is on the rise. The diagnosis of these diseases includes neuroimaging, in vitro diagnosis, and neuroinformatics.
- CT and MRI are the most commonly used imaging techniques across the globe, which are mainly used to detect brain abnormalities.
- Neurological biomarkers are extremely promising as they provide a direction to the diagnostic studies. Although currently, no commercial biomarker is available in the market, extensive clinical research is happening to find out the perfect combinations of the biomarkers.
- North America held the major market share of around 35.8% in 2023 and will retain its top position during the forecast period. On the other hand, Asia Pacific will exhibit the highest CAGR of 4.5% over the forecast period.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Neurodiagnostics Market Variables, Trends, & Scope
Chapter 4. Neurodiagnostics Market: Technology Estimates & Trend Analysis
Chapter 5. Neurodiagnostics Market: End Use Estimates & Trend Analysis
Chapter 6. Neurodiagnostics Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
- Canon Medical Systems Corporation
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Thermo Fisher Scientific, Inc.
- FUJIFILM Corporation
- Natus Medical Incorporated (Natus)
- Lifelines Neuro
- Advanced Brain Monitoring, Inc.
- NIHON KOHDEN CORPORATION.
- F. Hoffmann-La Roche Ltd
- GE HealthCare.
- Mitsar Co. LTD.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | August 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 17.54 Billion |
| Forecasted Market Value ( USD | $ 22.99 Billion |
| Compound Annual Growth Rate | 3.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
